Lusay, Bernard .
HRN: 10-30-23 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/24/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/24/2024
10/01/2024
IV
2gms
Q8
CAP MR
Rejected
Indication: Empirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Non-compliant To Guidelines